Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FS6ME
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $143,367
Award facts
- Contract value 100% obligated
- $143,366.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $143,366.66 delivery order to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
HEPLISAV-B is a recombinant hepatitis B vaccine indicated for adult immunization. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills vaccine and pharmaceutical delivery orders through the DLA Medical Supply Chain to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet specialized medical supply requirements through competitive procurement processes across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FS6ME?
SPE2DB25FS6ME was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FS6ME worth?
The government has obligated $143,367 on SPE2DB25FS6ME.
Is contract SPE2DB25FS6ME an order under another contract?
Yes. SPE2DB25FS6ME is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6ME competed?
The extent of competition for SPE2DB25FS6ME was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award